EGFR [epidermal growth factor receptor] pathway modulation in patients with ductal carcinoma in situ of the breast.
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2013
At a glance
- Drugs Gefitinib (Primary)
- Indications Early breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 22 Feb 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 24 Mar 2011 Actual end date (June 2005) added as reported by ClinicalTrials.gov.